Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Broich

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Nature Reviews. Drug Discovery|May 29, 2026
Better data for better medicines: a path to data-driven medicines regulationFrancois Domergue, Peter Arlett, Emer Cooke, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 5, 2021
[Digital health applications (DiGA) as an innovative component in digital healthcare in Germany-information, experiences, and perspectives]Wolfgang Lauer, Wiebke Löbker, Thomas Sudhop, et al.
Dialogues in Clinical Neuroscience|July 10, 2009
Biological markers for early detection and pharmacological treatment of Alzheimer's diseaseHarald Hampel, Karl Broich, Yvonne Hoessler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 12, 2024
[Establishment of the new "Health Data Lab" to provide data for science]Melanie Ludwig, Katharina Schneider, Steffen Heß, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2016
[Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn]Claudia Riedel, Birka Lehmann, Karl Broich, et al.
Journal of Neuroscience Methods|May 14, 2016
Sampling rate, signal bandwidth and related pitfalls in EEG analysisMarco Weiergräber, Anna Papazoglou, Karl Broich, et al.
Clinical Pharmacology and Therapeutics|November 19, 2021
Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing ValuePeter Arlett, Jesper Kjaer, Karl Broich, et al.
The New England Journal of Medicine|May 12, 2016
Drug Regulation and Pricing--Can Regulators Influence Affordability?Hans-Georg Eichler, Hugo Hurts, Karl Broich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
Addressing the regulatory and scientific challenges in multiple sclerosis--a statement from the EU regulatorsPavel Balabanov, Manuel Haas, Andre Elferink, et al.
Advances in Experimental Medicine and Biology|March 29, 2012
Voltage-gated Ca(2+) channel mediated Ca(2+) influx in epileptogenesisMagdalena Siwek, Christina Henseler, Karl Broich, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Nature Reviews. Drug Discovery|May 29, 2026
Better data for better medicines: a path to data-driven medicines regulationFrancois Domergue, Peter Arlett, Emer Cooke, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 5, 2021
[Digital health applications (DiGA) as an innovative component in digital healthcare in Germany-information, experiences, and perspectives]Wolfgang Lauer, Wiebke Löbker, Thomas Sudhop, et al.
Dialogues in Clinical Neuroscience|July 10, 2009
Biological markers for early detection and pharmacological treatment of Alzheimer's diseaseHarald Hampel, Karl Broich, Yvonne Hoessler, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 12, 2024
[Establishment of the new "Health Data Lab" to provide data for science]Melanie Ludwig, Katharina Schneider, Steffen Heß, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|October 26, 2016
[Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn]Claudia Riedel, Birka Lehmann, Karl Broich, et al.
Journal of Neuroscience Methods|May 14, 2016
Sampling rate, signal bandwidth and related pitfalls in EEG analysisMarco Weiergräber, Anna Papazoglou, Karl Broich, et al.
Clinical Pharmacology and Therapeutics|November 19, 2021
Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing ValuePeter Arlett, Jesper Kjaer, Karl Broich, et al.
The New England Journal of Medicine|May 12, 2016
Drug Regulation and Pricing--Can Regulators Influence Affordability?Hans-Georg Eichler, Hugo Hurts, Karl Broich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
Addressing the regulatory and scientific challenges in multiple sclerosis--a statement from the EU regulatorsPavel Balabanov, Manuel Haas, Andre Elferink, et al.
Advances in Experimental Medicine and Biology|March 29, 2012
Voltage-gated Ca(2+) channel mediated Ca(2+) influx in epileptogenesisMagdalena Siwek, Christina Henseler, Karl Broich, et al.
Pageof 10